Re: Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery
Colorectal Dis
.
2019 Jan;21(1):119-120.
doi: 10.1111/codi.14472.
Epub 2018 Dec 3.
Authors
A Sun Myint
1
2
,
A Dhadda
3
,
C Rao
4
,
R Sripadam
1
,
K Whitmarsh
1
,
J P Gerard
5
;
International Contact Radiotherapy Network (ICONE)
Affiliations
1
Clatterbridge Cancer Centre NHS Foundation Trust, Papillon Suite, Wirral, UK.
2
Translational Research Department, University of Liverpool, Liverpool, UK.
3
Radiation Oncology, Castle Hill Hospital, Hull, UK.
4
Division of Cell and Molecular Biology, Colorectal Surgery, Imperial College London, London, UK.
5
Radiotherapy, Centre Antoine-Lacassagne, Nice, France.
PMID:
30427583
DOI:
10.1111/codi.14472
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Incidence
Neoadjuvant Therapy
Rectal Neoplasms*